Pentostatin shortage status
1 active shortage notice across 1 country.
Last updated 17 Sept 2026 · sourced from official medicines regulators
- Generic name (INN)
- Pentostatin
- Brand names
- Nipent
- Class
- Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper
Where Pentostatin is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | critical | 1 | 27 Aug 2026 | — | FDA |
Why Pentostatin is in shortage
- causes not stated by the regulator — e.g. “Next delivery: Q2 2027; Estimated recovery: Q3 2027; Shortage per manufacturer: manufacturing delays” (United States)
Frequently asked questions
Is Pentostatin currently in shortage?
Yes. As of the latest regulator updates, Pentostatin has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Pentostatin in shortage?
Regulators attribute the current Pentostatin shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Pentostatin shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Pentostatin status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.